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OBJECTIVES We evaluated in humans the safety and efficacy of a novel magnetic guidance system (MGS)
for electrophysiological mapping, pacing, and ablation.
BACKGROUND Catheter ablation of atrial fibrillation and other complex arrhythmias requires precise catheter
manipulation and stabilization. We have shown in animals that the MGS can precisely
manipulate a mapping catheter within the heart with an external magnetic field rather than
manual catheter control.
METHODS Thirty-one adults referred for diagnostic electrophysiology studies were enrolled in a
prospective trial of the MGS. The magnetic catheter was navigated to preselected sites in the
right atrium (RA) and right ventricle (RV) in the first 20 patients. Electrograms were
recorded at each target site, and pacing thresholds were measured. In a subset of five patients,
RA and RV electrograms and stimulation thresholds were recorded with both a standard
ablation catheter and the magnetic catheter. Eleven additional patients were recruited for
supraventricular tachycardia (SVT) mapping, and seven of these underwent ablation.
RESULTS Navigation was successful in 200 of 202 predetermined right-sided navigation targets and 13
of 13 targets in the left atria. Pacing thresholds and electrogram amplitudes in the RA and
RV were not significantly different between the standard and magnetic catheters. The SVT
mapping with the magnetic catheter was successful in 13 patients, including 4 with left-sided
accessory pathways. The MGS was used for successful ablation of SVT in seven of seven
patients. There were no procedural complications.
CONCLUSIONS These results demonstrate that the MGS can be used for intracardiac mapping, pacing, and
ablation safely and effectively. (J Am Coll Cardiol 2003;42:1952–8) © 2003 by the
American College of Cardiology Foundation
Catheter ablation of complex arrhythmias requires precise
manipulation and stability of the ablation catheter for
success. Challenges characteristic of difficult ablation pro-
cedures include long procedure times, extended fluoroscopic
exposure to the patient and physician, and a greater risk of
arrhythmia recurrence. Limitations of conventional manu-
ally deflected ablation catheters may contribute to these
challenges. Magnetic force has been used for intravascular
catheter manipulation beginning with the work of Tillander
(1), who restricted his study to manipulation of a catheter to
major branches of the aorta. Ram and Meyer (2) demon-
strated the first use of this methodology in humans. These
initial efforts were limited by the low field strength and large
size of available electromagnets as well as a lack of precise,
three-dimensional control of the magnetic field vector.
Subsequent developments have incorporated stereotactic
localization and computer-controlled vectors for improved
guidance (3). A magnetically guided ablation catheter
promises to address the constraints of conventional ablation
catheters that depend on mechanical deflection mecha-
nisms.
We have participated in the development of a novel
magnetic guidance system (MGS) for intracardiac electro-
physiological procedures (4). In animals, we have demon-
strated that magnetic catheter navigation is precise and
compatible with intracardiac pacing, electrogram recording,
and endocardial radiofrequency ablation. The endocardial
force exerted by the magnetic catheter is comparable to that
exerted by a standard deflectable catheter, and the risk of
endocardial injury appears to be minimal.
This is the first prospective human trial of the MGS. The
study objectives were to demonstrate the equivalence of the
magnetic catheter performance to a standard 4-mm-tip
ablation catheter and to document the safety and efficacy of
the MGS for intracardiac recording, mapping, pacing, and
radiofrequency ablation.
METHODS
MGS. The trial was performed with the MGS (Ster-
eotaxis, Inc., St. Louis, Missouri), which manipulates a
specially designed electrophysiology catheter with an exter-
nal magnetic field. The 7F magnetic catheter contains a
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small permanent magnet in the tip that interacts with the
prevailing magnetic field. The magnetic field exerts a force
on the permanent magnet located in the catheter tip (4).
The magnitude of the force exerted on the catheter is
maximal when the catheter is perpendicular to the magnetic
field and goes to zero when the catheter aligns parallel to the
magnetic field. Animal studies have demonstrated that the
0.15T field strength utilized by the MGS exerts a force on
the catheter comparable to that achieved with a standard
manual deflection mechanism. The magnetic catheter and
the MGS are shown in Figure 1. The MGS consists of a
housing containing three orthogonal electromagnets cooled
by liquid helium, biplanar digital fluoroscopic imaging
plates that are unaffected by the magnetic field, and a
conventional fluoroscopy table. Directional catheter naviga-
tion is performed with a graphical user interface (Fig. 2A).
A desired magnetic field vector is drawn on a digitization
tablet and displayed on orthogonal fluoroscopic views, as
shown in Figure 2B. A control computer then calculates the
appropriate currents to each of the superconducting electro-
magnets to produce the chosen composite magnetic field
vector. The resolution of the MGS is 1°. Typical manip-
ulations of the magnetic field vector require from 5 to 20 s
for the MGS to redirect the field vector in a new direction,
with time proportional to the magnitude of the directional
change.
Trial design. The objectives of the trial design were to test
the safety and efficacy of the MGS for intracardiac naviga-
tion, recording, and pacing. The primary end point for the
trial was successful navigation and recording at preselected
intracardiac targets within the right atrium (RA) and right
ventricle (RV). The secondary end point for the trial was the
measurement of stimulation thresholds with the magnetic
catheter within the RA and RV. The efficacy of the MGS
Abbreviations and Acronyms
AV  atrioventricular
ECG  electrocardiogram
LAO  left anterior oblique
MGS  magnetic guidance system
RA  right atrium
RAO  right anterior oblique
RV  right ventricle/ventricular
SVT  supraventricular tachycardia
Figure 1. Magnetic catheter and magnetic guidance system (MGS) (A)
Photographs of the 7F magnetic catheter. A closeup of the catheter tip is
shown on the right. A permanent magnet embedded within the tip of the
catheter interacts with a prevailing magnetic field. A standard, platinum
4-mm-tip electrode and a proximal ring electrode are used for endocardial
recording and pacing. The scale bar is 20 mm. (B) A photograph of the
MGS. This system consists of a housing that surrounds the patient’s torso;
the system also contains an electromagnetic array, a digital biplanar
fluoroscope, a standard fluoroscopy table, and a graphical workstation for
catheter navigation. The system is shown with the fluoroscopy table
withdrawn from the electromagnet housing.
Figure 2. Magnetic navigation. (A) Photograph of catheter navigation
with the magnetic guidence system. The catheter is guided by drawing a
magnetic field vector on a graphical digitization tablet at the side of the
fluoroscopy table as shown. The magnetic field vector is drawn and
displayed overlying two orthogonal fluoroscopic views to specify a unique
three-dimensional magnetic field vector. The magnetic field is then
activated through the digitization tablet, and the catheter aligns parallel
with the selected magnetic field vector. (B) Orthogonal fluoroscopic views
used to specify the magnetic field vector. The images displayed (left
anterior oblique [left], right anterior oblique [right]) show the magnetic
catheter aligning parallel to the chosen magnetic field vector to reach the
His bundle recording site in a patient.
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was assessed by the achievement of the end points of the
study. The sample size of 200 intracardiac navigation
targets, 10 sites in each of 20 patients, was chosen to
determine the navigation success rate within 4%. Navigation
success at a particular site was judged fluoroscopically and
electrophysiologically. Catheter performance was also as-
sessed by measurement of stimulation thresholds at two
sites, the RA and RV, in each patient. Successful stimula-
tion was defined as a threshold of4 mA. With this sample
size (40 sites), the study had 80% power to detect a
difference between a successful stimulation rate of 98% and
a successful stimulation rate of 100%.
After 20 patients were recruited, the trial was expanded to
include navigation to left atrial and left ventricular sites as
well as ablation of supraventricular tachycardia (SVT). The
catheter used for patients undergoing ablation has been
modified from the original to include a thermocouple for
temperature control. This trial expansion is ongoing, but
data from the first seven patients are included in this
publication for SVT ablation and navigation to left-sided
targets.
Prior work in experimental animals (4) investigated the
risk of cardiac perforation with the MGS by attempting to
navigate outside the cardiac silhouette. This catheter ma-
nipulation did not cause any histological damage to the
endocardial surface. The safety of the MGS was assessed in
the present trial in two ways. First, a complete echocardio-
graphic evaluation with Doppler studies was performed
immediately before and after catheter navigation with the
MGS. In addition, patients had a telephone interview
performed 7 to 10 days later to assess their recovery from the
procedure. The safety of the MGS was prospectively stated
as an absence of serious complications of the procedure
defined as structural heart damage visible by echocardiog-
raphy, pericardial effusion, hypotension, or death.
Electrogram comparisons were made by an electrophysi-
ologist blinded to the identity of the catheter associated with
a particular recording. The electrograms were judged as
either acceptable or unacceptable.
Inclusion criteria. The trial was conducted with the ap-
proval and oversight of the Washington University Human
Studies Committee. Patients able to give informed consent
who were referred to the clinical cardiac electrophysiology
service for diagnostic electrophysiology testing were re-
cruited for the trial. Only patients older than 18 years were
considered for recruitment. Patient characteristics are given
in Table 1.
Exclusion criteria. Patients were excluded if they could not
be safely exposed to a magnetic field owing to implanted
devices such as a cardioverter-defibrillator, pacemaker, or
vascular clips. Other exclusion criteria included left bundle
branch block, body weight 300 pounds, claustrophobia,
hemodynamic instability, recent myocardial infarction, re-
cent cardiac surgery, or ongoing participation in experimen-
tal protocols.
Experimental protocol. Patients who had given informed
consent underwent a complete echocardiogram prior to
catheter navigation. Monitored conscious sedation was es-
tablished and maintained with intravenous fentanyl and
midazolam during the procedure. Monitoring instruments
were compatible with magnetic fields used in this study.
Intravascular sheaths were placed in the right and left
femoral veins. The magnetic catheter was introduced into
the femoral venous access sheath and manually advanced to
the region of the RA. Navigation was performed sequen-
tially to each predefined target: high RA, His bundle, lateral
tricuspid valve annulus, posterior tricuspid valve annulus,
His bundle, and the right ventricular apex. In addition to
predefined targets, five additional navigation targets were
selected by the operator at the time of the procedure.
Navigation success was judged by analysis of intracardiac
electrograms and biplanar fluoroscopic views. Stimulation
thresholds were also measured at the high RA and the RV
apex. At the conclusion of the magnetic catheter navigation,
a second echocardiogram was performed. The patient then
underwent the scheduled diagnostic electrophysiology study
with standard catheters. In a subset of five patients, this
included use of a standard 4-mm-tipped deflectable ablation
catheter for navigating, recording, and mapping at the same
sites as the magnetic catheter.
Electrogram recording and pacing. All procedures were
performed with a standard multichannel amplifier (Prucka
Engineering Inc., Houston, Texas). Intracardiac electro-
grams were filtered with a bandpass of 30 to 400 Hz and
digitized via an analog-to-digital converter at a rate of 1,000
samples/s. Surface electrocardiograms (ECGs) were filtered
with a bandpass of 0.05 to 120 Hz prior to digitization at
the same sampling rate. Stimulation was performed with a
standard, isolated multichannel stimulator (Bloom Inc.). All
electrograms were stored optically for analysis. Electrogram
analysis was performed with the software package provided
with the recording system (Prucka Engineering Inc.).
Statistical analysis. A Student t test was used for compar-
ison of pacing thresholds, electrogram amplitude, and radi-
ation exposure between the magnetic catheter and the
conventional catheter.
RESULTS
Electrogram recordings. Surface ECGs and intracardiac
electrograms recorded with both a magnetic catheter and a
Table 1. Patient Characteristics
M (n)/F (n) 18/13
Age average, yrs (range) 52 (20–77)
Weight average, lb (range) 179 (120–262)
Indication for electrophysiologic study
Supraventricular tachycardia 15
Nonsustained ventricular tachycardia 7
Atrial flutter 3
Wolff-Parkinson-White syndrome 5
Syncope 1
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standard 4-mm-tipped ablation catheter from a single
patient with Wolff-Parkinson-White syndrome are shown
in Figure 3. Intracardiac electrograms recorded with the
MGS were qualitatively unaffected by the presence of the
magnetic field. Both catheters recorded similar electrograms
at the site of the ventricular insertion of the accessory
pathway located on the lateral tricuspid valve annulus. All
electrogram recordings were judged to be acceptable by a
blinded electrophysiologist.
Navigation success in the RA and RV. Catheter naviga-
tion was successful to 213 of 215 attempted sites. Table 2
summarizes the results of navigation to all intracardiac
targets and the navigation success rate at each site. The
catheter failed to reach the RV apex in two patients. In one
of these, chamber dilation prevented both the conventional
and magnetic catheters from reaching the navigation target
in the RV apex. The magnetic catheter design was modified
after the first 20 patients to minimize the catheter transition
point that appeared to limit extension of the catheter to the
ventricular apex. This problem was not observed in subse-
quent studies. Figure 4 shows the distribution of sites
mapped on the tricuspid annulus. Navigation to all sites
around the tricuspid valve annulus was successful.
Stimulation thresholds. Pacing thresholds were measured
with the magnetic catheter at the high RA and RV apex in
all 20 patients. The stimulation thresholds at these sites
were in the expected range for a 4-mm-tip mapping
catheter. Stimulation thresholds were 1.3 mA (range 0.1 to
2.4 mA, 2 ms pulse width) in the RA and 1.0 mA (0.2 to 2.0
mA, 2 ms pulse width) in the RV apex.
Equivalence with a standard catheter. In a subset of five
patients, intracardiac electrograms and stimulation thresh-
olds were recorded at the high RA and RV apex with both
the magnetic catheter and a standard 4-mm-tipped ablation
catheter. Electrogram amplitudes and stimulation thresh-
olds were not significantly different between the two cath-
eters. The average (range) electrogram amplitude recorded
in the RA with the magnetic catheter was 2.2 mV (0.8 to
5.9 mV) compared to 1.9 mV (1.1 to 2.8 mV) recorded with
the standard catheter. The average (range) electrogram
Figure 3. Electrogram recordings with a magnetic catheter. Surface elec-
trocardiograms (ECGs) and intracardiac electrograms recorded from a
single patient with Wolff-Parkinson-White syndrome are shown. Intra-
cardiac recordings made with both a standard 4-mm-tipped ablation
catheter and the magnetic catheter at the high right atrium (HRA), right
ventricle apex (RVA), His bundle (His), and ventricular insertion of the
accessory pathway are shown. Electrograms were recorded sequentially
from the recording sites and are displayed in registry with the surface
ECGs. Surface and intracardiac electrograms were not compromised by the
magnetic field. The vertical scale is 5 mV, and the horizontal scale is 400
ms.
Table 2. Magnetic Guidance System Navigation Success
Navigation Target Success/Attempt
High right atrium 20/20
His bundle 20/20
Posterior tricuspid valve annulus 20/20
Lateral tricuspid valve annulus 20/20
Right ventricular apex 18/20
Right ventricular free wall 10/10
Right ventricular outflow tract 6/6
Right ventricular septum 11/11
Other tricuspid valve annulus sites 75/75
Left atrium 13/13
Figure 4. Tricuspid annulus recording sites. The distribution of recording
sites located around the tricuspid valve are shown schematically. Each
recording site was targeted in the left anterior oblique fluoroscopic
projection. Recording sites were categorized by the analogous hour position
on a clock face. All navigation attempts to sites around the tricuspid
annulus were successful. An example of a recording site at the lateral (Lat)
aspect (9:00) on the tricuspid valve annulus (TVA) is shown in right
anterior oblique (left) and left anterior oblique (right) images. The septal
(Sep), anterior (Ant), and posterior (Post) tricuspid annulus are indicated
for orientation.
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amplitude recorded in the RV apex with the magnetic
catheter was 2.2 mV (0.8 to 5.9 mV) compared to 2.8 mV
(1.7 to 5.4 mV) recorded with the standard catheter. The
average (range) stimulation threshold recorded in the RA
with the magnetic catheter was 1.3 mA (0.1 to 2.4 mA)
compared to 1.2 mA (1.0 to 1.5 mA) recorded with the
standard catheter. The average (range) stimulation thresh-
old recorded in the RV apex with the magnetic catheter was
1.0 mA (0.2 to 2.0 mA) compared to 0.6 mA (0.2 to 0.8
mA) recorded with the standard catheter.
Mapping and ablation of SVT. Intracardiac recordings
were made with the magnetic catheter in 13 patients with
SVT. Manifest accessory pathways were present in five
patients. One pathway was located on the lateral aspect of
the tricuspid annulus, and four were located around the
mitral valve annulus. In addition, there were seven patients
with atrioventricular (AV) nodal re-entry, and one with
atrial flutter. In three patients with left lateral accessory
pathways, the magnetic catheter was introduced into the left
atrium through a trans-septal sheath, and in the other a
retrograde aortic approach was used. Figure 5 demonstrates
navigation of the magnetic catheter to recording sites within
each pulmonary vein in that patient. Figure 6 is an example
of recordings, in the same patient, made with the magnetic
catheter positioned at the site of a left posterolateral
accessory pathway during sinus rhythm and during ortho-
dromic AV re-entrant tachycardia. Intracardiac recordings
obtained at the sites of all five accessory pathways were
qualitatively equivalent to those obtained with a conven-
tional catheter. The magnetic catheter was also successfully
directed to left paraseptal, mid-posterior, and lateral sites
along the mitral annulus as defined by the electrodes of the
decapolar coronary sinus catheter. In each of the 13 patients
who underwent mapping of SVT, the magnetic catheter was
guided to a stable position within the reentrant circuit of the
arrhythmias, and satisfactory electrograms were recorded. In
seven of seven patients with SVT, the magnetic catheter was
used for successful ablation of the arrhythmia mechanism
(five patients with AV nodal re-entry, two patients with
accessory pathways). No complications occurred from the
ablation procedures.
Safety. There were no cardiac structural abnormalities
noted on echocardiograms due to magnetic catheter navi-
gation. In addition, no serious adverse events occurred. One
patient developed nausea during the procedure, which was
self-limited and did not necessitate termination of the
procedure. There were no cases of vascular injury. Phone
interviews performed seven to ten days after the procedure
did not detect any adverse sequalae of the procedure.
Fluoroscopic exposure during mapping. In the subset of
five patients in whom the magnetic catheter and a standard
catheter were compared, total fluoroscopy times required by
three different investigators for intracardiac navigation to
ten endocardial sites and pacing at two sites (RA and RV
apex) were compared. The total fluoroscopy times in min-
utes (average  SD) were for the magnetic catheter 4:24 
2:14 and for the standard catheter 5:19  1:23. Although
there was a trend for a reduced fluoroscopic exposure with
the magnetic catheter navigation, this did not reach statis-
tical significance (p  0.43).
DISCUSSION
This study is the first human trial of a magnetically guided
catheter for intracardiac mapping and ablation of SVT. Our
results demonstrate that magnetic force can be used to
precisely navigate an electrophysiology catheter within all
four chambers of the heart in humans for intracardiac
mapping, stimulation, and radiofrequency ablation. Intra-
cardiac electrograms and stimulation thresholds were not
significantly different from those recorded with a standard,
manually deflected ablation catheter. In addition, the mag-
netic catheter was used to perform accurate intracardiac
mapping and recording in patients with supraventricular
arrhythmias. The results of this trial suggest that the safety
of standard electrophysiological procedures in not compro-
mised by the MGS.
The MGS is an evolving technology. The initial proto-
type magnetic catheter failed to reach the right ventricular
apex in two patients. The failure appeared to be due to the
abrupt transition in catheter stiffness between the proximal
shaft and the distal segment. At this site, the proximal
Figure 5. Pulmonary vein mapping with a magnetic catheter. The mag-
netic catheter was introduced into the left atrium through a trans-septal
sheath for left atrial mapping in a patient with a left posterolateral accessory
pathway. Navigation of the magnetic catheter to each pulmonary vein is
shown in left anterior oblique images: (A) left superior pulmonary vein; (B)
right superior pulmonary vein; (C) left inferior pulmonary vein; (D) the
right inferior pulmonary vein.
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segment of the catheter prolapsed behind the tricuspid
annulus when it was advanced toward the right ventricle.
This problem was not observed with the subsequent cath-
eter design, which reduced the transition point to the distal
segment. Validation of the new catheter design was per-
formed in experimental animals (4) and humans for the final
six patients reported in the present study.
A potential limitation of the MGS is the interference
induced by the magnetic field in the surface ECGs. A
similar interference has been described with electrocardiog-
raphy in association with magnetic resonance imaging (5).
The origin of the induced potential is thought to be
attributable to blood flow within the magnetic field. Blood
is an electrolyte solution that may induce the potential
owing to motion within the magnetic field. The magnitude
of this interference was minimal in the inferior leads of the
ECG, and the temporal distribution of the interfering signal
component probably would not compromise cardiac rhythm
analysis, analysis of P-wave, or QRS morphology. However,
interpretation of changes in the ST-segment would be
predictably compromised by this interference.
The MGS offers potential advantages over standard
catheter systems. Remote control of the MGS is possible
from a workstation that would facilitate simultaneous cath-
eter navigation and electrogram analysis, and would elimi-
nate radiation exposure to the physician. In addition,
catheter mobility and endocardial stability may be superior
by virtue of the compliance of the distal catheter and a lack
of constraints on the magnetic vector used to steer the
catheter. Cardiac and respiratory motion may be buffered by
the catheter compliance, thereby contributing to endocar-
dial contact stability. A unique feature of the current MGS,
which is a subsequent modification of the system used for
the present trial, is that the magnetic vector coordinates
used to navigate the magnetic catheter to a particular site
can be stored and reused later in the study to return to a site
of interest. The compliance of the catheter and lack of
directional constraints on the magnetic vector differ from
standard, manually deflected catheters; however, further
study is needed to determine whether the MGS is superior
to a conventional catheter. The next generation of the MGS
is designed to improve speed and accuracy of navigation to
Figure 6. Magnetic catheter recordings in a patient with Wolff-Parkinson-White syndrome. The magnetic catheter was introduced into the left atrium by
a trans-septal sheath and directed onto the site of a left posterolateral accessory pathway. The right anterior oblique (left) and left anterior oblique (right)
projections are shown of the magnetic catheter positioned at the accessory pathway recording site. Catheters are also shown recording from the right
ventricular apex, the His bundle recording site, and within the coronary sinus. Electrogram recordings were made with the magnetic catheter at the accessory
pathway site during sinus rhythm and during orthodromic atrioventricular re-entrant tachycardia. Concurrent proximal His (pHis) and distal His (dHis)
readings are shown. The vertical scale is 3 mV, and the vertical scale is 400 ms. NSR  normal sinus rhythm; SVT  supraventricular tachycardia.
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sites that are exceptionally difficult to reach with a standard
catheter.
Study limitations. A principal limitation in this study was
the restriction of navigation targets to the RA and RV in the
first 20 patients, which was imposed to protect patient safety
for initial tests of the MGS. Most of the targeted endocar-
dial sites are readily reached with a standard, manually
deflected catheter. Exceptions may be the lateral and an-
terolateral tricuspid valve annulus and pulmonary vein ostia
where catheter stability can be problematic. At these sites,
the MGS appeared to perform well. The current MGS does
not offer a distinct advantage over conventional catheters for
navigation to targets that are easily reached. Based on our
experience in animal studies and the limited experience in
humans, the investigators believe the MGS has potential
advantages for complex catheter maneuvers, but the current
study was not designed to prove this point.
Patients with claustrophobia, obesity, or pacemakers and
defibrillators were excluded from the trial because of the
restricted space within the MGS or electromagnetic inter-
ference, respectively. The next generation of the MGS
features an open design that is more comfortable for
patients with claustrophobia or morbid obesity. Further
study is required to determine whether the magnetic field
strength is compatible with pacemakers or internal
cardioverter-defibrillators. The magnetic field strength used
for catheter manipulation is about one order of magnitude
less than that associated with magnetic resonance imaging.
The interaction of the magnetic field with the surface ECG
is, therefore, less in magnitude to magnetic resonance
imaging, and restricted to the ST-segment. Whether this
distortion will affect arrhythmia analysis will be investigated
in the ongoing SVT ablation trial.
This study represents our initial experience with the
MGS in humans and the transition from the first to second
magnetic catheter designs. Our use of the system was
constrained by caution and protocol stipulations. The trial
was not designed to prove the superiority of the MGS over
conventional steering mechanisms and should not be con-
strued in that context.
Conclusions. This study confirms the feasibility of deploy-
ing a novel magnetically guided catheter for electrophysiol-
ogy studies and ablation of arrhythmias in humans. The
MGS directed the catheter to specific targets in the RA,
RV, and left atrium safely and effectively.
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